The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI)
Recruiting
N/A
Interventional Study
Acute Kidney Injury
Intensive Care
Renal Replacement Therapy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 3,600 (estimated)
- Sponsor
- Huede Healthtech Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
"Huede" AI Aided AKI Prediction Software, Acura AKI, uses machine learning algorithms to predict the risk of AKI within the next 24 hours and provide a ranking of feature importance. By using Acura AKI, physicians can assess the risk of AKI, focusing on high-risk patients to provide care decisions. This study will be conducted in a prospective randomized clinical trial in adult ICUs, implementing …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Over 20 years old
* Admitted to adult ICU
* Hospital stay of more than 30 hours
Exclusion Criteria:
* Known to have acute kidney injury at enrollment
* Currently undergoing hemodialysis treatment
* No available blood or urine test data
* Pregnant women
* HIV-positive patient…
Contacts